Elevated levels of bile-derived cfDNA markers, syncytin-1 and SLC7A11, were identified in cholangiocarcinoma patients compared to those with gallstones, demonstrating significant potential for early diagnosis. Researchers noted an area under the curve (AUC) of 0.805 for syncytin-1 and 0.755 for SLC7A11, indicating robust specificity, while the combination of these markers with CA19-9 significantly improved diagnostic […]

TEAD1 expression correlates with liver regeneration outcomes in patients undergoing ALPPS, a two-stage surgical procedure. Analysis of tumor-free liver tissue from 44 patients reveals that nuclear and cytoplasmic scores of TEAD1 serve as predictive markers for clinical outcomes. The study also notes that TEAD family members are expressed in individual hepatocytes, indicating relationships with regeneration […]

A systematic review and meta-analysis evaluated minimally invasive associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) compared to open methods. Findings revealed a significant reduction in 90-day mortality (risk ratio = 0.48) and overall length of hospital stay (mean difference = -8 days) for minimally invasive procedures. Efficacy remained comparable regarding liver […]

A predictive model for identifying intrahepatic collateral vessels in patients with caval confluence tumors reveals that 78% exhibited such vessels. Out of those, 92% underwent parenchyma-sparing hepatectomies, with zero operative mortality and no liver congestion reported. The study established tumor size, number, hepatic vein infiltration, and tissue density as key predictors for the presence of […]

Between 1990 and 2021, gallbladder and biliary tract cancer (GBTC) saw a substantial increase, with new cases rising by 101.09% and deaths by 74.26%. In 2021, there were approximately 216,768 new cases and 171,961 deaths globally, predominantly affecting females and older adults. Although age-standardized incidence and death rates have trended downward over the years, projections […]

A Phase II trial demonstrated that combining irreversible electroporation (IRE) with β-glucan significantly improved disease-free intervals and overall survival in patients with stage III pancreatic ductal adenocarcinoma. The study included 30 patients treated with IRE followed by β-glucan, showing a median disease-free interval of 18 months and a median overall survival of 32.5 months. Notably, […]